The Bochum Optimizing Clopidogrel-Aspirin Therapy and MORTality Study (BOCLA-Mort)
NCT01796691
·
clinicaltrials.gov ↗
COMPLETED
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Sponsor
Ruhr University of Bochum